In late 2020 and early 2021, DiMe and hih held roundtable discussions with experienced international experts in evidence generation for digital medicine products. These products included tools driven by high-quality hardware and software that support the practice of medicine broadly – including treatment, recovery, disease prevention, and health promotion for individuals and across populations.

On Feb. 23, 2022, DiMe and hih released global priorities for digital health innovations in a The Lancet Digital Health article, “Advancing digital health applications: Priorities for innovation in real-world evidence (RWE) generation”.

The viewpoint identified key opportunities for better practices in evidence generation. It also highlighted methodological challenges and outstanding questions to inform future research. Advancing these topics and international agreement on definitions and best practices is vital to the safe and effective deployment of digital health applications in Germany. This model can also be adopted internationally in many ways.